Adaptive Biotechnologies Corp Insider Trading for May 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adaptive Biotechnologies Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Adaptive Biotechnologies Corp for May 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 19 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | M | 7.80 | 2,500 | 19,500 | 76,000 | |
| May 19 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Sell | S | 35.00 | 2,500 | 87,500 | 1,504 | 4 K to 1.5 K (-62.44 %) |
| May 19 2021 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Buy | M | 7.80 | 2,500 | 19,500 | 4,004 | 1.5 K to 4 K (+166.22 %) |
| May 17 2021 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Option Exercise | M | 7.80 | 2,000 | 15,600 | 151,000 | |
| May 17 2021 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Sell | S | 33.80 | 2,000 | 67,600 | 20,604 | 22.6 K to 20.6 K (-8.85 %) |
| May 17 2021 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Buy | M | 7.80 | 2,000 | 15,600 | 22,604 | 20.6 K to 22.6 K (+9.71 %) |
| May 13 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.55 | 10,000 | 65,500 | 130,000 | |
| May 13 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Option Exercise | M | 6.55 | 10,000 | 65,500 | 140,000 | |
| May 13 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 32.63 | 10,000 | 326,300 | 21,604 | 31.6 K to 21.6 K (-31.64 %) |
| May 13 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.55 | 10,000 | 65,500 | 31,604 | 21.6 K to 31.6 K (+46.29 %) |
| May 13 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 31.84 | 7,031 | 223,867 | 21,604 | 28.6 K to 21.6 K (-24.55 %) |
| May 13 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Sell | S | 30.81 | 2,969 | 91,475 | 28,635 | 31.6 K to 28.6 K (-9.39 %) |
| May 13 2021 | ADPT | Adaptive Biotechno ... | Cohen Chad M | Chief Financial Off ... | Buy | M | 6.55 | 10,000 | 65,500 | 31,604 | 21.6 K to 31.6 K (+46.29 %) |
| May 07 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 3,895 | 24,616 | 128,535 | |
| May 07 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 3,895 | 24,616 | 132,430 | |
| May 07 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 36.38 | 847 | 30,814 | 69,360 | 70.2 K to 69.4 K (-1.21 %) |
| May 07 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 35.51 | 3,048 | 108,234 | 70,207 | 73.3 K to 70.2 K (-4.16 %) |
| May 07 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 3,895 | 24,616 | 73,255 | 69.4 K to 73.3 K (+5.62 %) |
| May 07 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 35.43 | 3,195 | 113,199 | 69,360 | 72.6 K to 69.4 K (-4.40 %) |
| May 07 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 3,895 | 24,616 | 73,255 | 69.4 K to 73.3 K (+5.62 %) |
| May 06 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 3,895 | 24,616 | 136,325 | |
| May 06 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 36.80 | 700 | 25,760 | 69,360 | 70.1 K to 69.4 K (-1.00 %) |
| May 06 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 35.99 | 3,195 | 114,988 | 70,060 | 73.3 K to 70.1 K (-4.36 %) |
| May 06 2021 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 3,895 | 24,616 | 73,255 | 69.4 K to 73.3 K (+5.62 %) |
| May 03 2021 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Option Exercise | M | 31.71 | 1,354 | 42,935 | 46,042 | |
| May 03 2021 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Option Exercise | M | 6.55 | 1,770 | 11,594 | 19,480 | |
| May 03 2021 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Option Exercise | M | 7.80 | 1,042 | 8,128 | 25,000 | |
| May 03 2021 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Sell | S | 41.93 | 4,166 | 174,680 | 15,036 | 19.2 K to 15 K (-21.70 %) |
| May 03 2021 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Buy | M | 31.71 | 1,354 | 42,935 | 19,202 | 17.8 K to 19.2 K (+7.59 %) |
| May 03 2021 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Buy | M | 6.55 | 1,770 | 11,594 | 17,848 | 16.1 K to 17.8 K (+11.01 %) |
| May 03 2021 | ADPT | Adaptive Biotechno ... | Taylor Stacy L | SVP and General Cou ... | Buy | M | 7.80 | 1,042 | 8,128 | 16,078 | 15 K to 16.1 K (+6.93 %) |